Regulus Therapeutics Inc (NASDAQ:RGLS)

1.23
Delayed Data
As of Feb 20
 +0.03 / +2.50%
Today’s Change
0.79
Today|||52-Week Range
1.95
+18.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-18.7M-56.7M-55.7M-81.8M
 
 
 
 
 
Depreciation1.4M1.5M1.6M2.3M
 
 
 
 
 
Total Other Cash Flow6.0M20.8M18.7M14.6M
 
 
 
 
 
Funds From Operations-11.3M-34.4M-35.4M-65.0M
 
 
 
 
 
Funds From/For Other Operating Expenses17.0M5.1M14.5M-8.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-28.3M-39.5M-49.9M-56.9M
 
 
 
 
 
 
InvestingIncrease In Investments-72.0M-113.4M-78.4M-65.1M
 
 
 
 
 
Decrease In Investments32.0M85.4M101.3M101.4M
 
 
 
 
 
Capital Expenditures-800.0K-1.1M-1.4M-913.0K
 
 
 
 
 
Net Cash Flow Investing-40.9M-29.2M21.5M35.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.000.000.0019.8M
 
 
Long Term Debt Reduction-100.0K-142.0K-155.0K--
 
 
 
 
Net Proceeds Stock Sale46.6M88.4M7.2M951.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00167.0K
 
 
Net Cash Flow - Financing46.5M88.2M7.0M20.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash-22.7M19.5M-21.4M-1.0M